Baseline/postnitrate tetrofosmin SPECT for myocardial viability assessment in patients with postischemic severe left ventricular dysfunction: New evidence from MRI

Journal of Nuclear Medicine

Volumn 46, Issue 8, 2005, Pages 1285-1293

  Giorgetti, Assuero ^a   Pingitore, Alessandro ^a   Favilli, Brunella ^a   Kusch, Annette ^a   Lombardi, Massimo ^a   Marzullo, Paolo ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Contrast enhanced MRI; Gated SPECT; Myocardial viability; Nitrates

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; ISOSORBIDE DINITRATE; TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; NITRATE; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GATED IMAGING; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HEART SCINTISCANNING; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EXERCISE TEST; HEART; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; EXERCISE TEST; FEMALE; GADOLINIUM DTPA; HEART; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; NITRATES; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 25444531140     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Maes AF, Borgers M, Flameng W, et al. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT: correlation with histologic and positron emission tomographic studies and functional Follow-up. J Am Coll Cardiol 1997;29:62-63.
2. 99mTc-sestamibi. Circulation 1994;89:2552-2561.
3. 99mTc-sestamibi tomography before coronary artery by-pass graft surgery: correlation with histopathologic and postoperative improvement in cardiac function. Circulation 1997;96:2982-2933.
4. Galli M, Marcassa C, Imparato A, Campini R, Orrego PS, Giannuzzi P. Effect of nitroglycerin by technetium-99m sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patiente with healed myocardial infarction. Am J Cardiol 1994;74:343-343.
5. Bisi G, Sciagra R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994;24:1282-1289.
6. Li ST, Liu XJ, Lu ZL, et al. Quantitative analysis of technetium 99m-methoxyisobutyl isonitrile single-photon emission computer tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularization. J Nucl Cardiol 1996;3:457-463.
7. Flotats A, Carrio I, Estorch M, et al. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single photon emission tomography. Eur J Nucl Med 1997;24:767-773.
8. 18FDG-positron emission tomography imaging. J Nucl Cardiol 2004;11:142-151.
9. 18F fluorodeoxyglucose in patients with chronic coronary artery disease: a functional and morphological approach to the detection of residual myocardial viability. Circulation 1995;91:1006-1015.
10. van Rugge FP, van der Wall EE, van Dijkman PR, Louwerenburg HW, de Roos A, Bruschke AV. Usefulness of ultrafast magnetic resonance imaging in healed myocardial infarction. Am J Cardiol 1992;70:1233-1237.
11. Geskin G, Kramer CM, Rogers WJ, et al. Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 1998;98:217-223.
12. 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998;98:1869-1874.
13. Kim RJ, Fieno DS, Parrish TE, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1990;100:1992-2002.
14. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36:1985-1991.
15. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulate 2000;102:1678-1683.
16. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-167.
17. Kim RJ, Wu E, Rafael A, et al. The use of contrast enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453.
18. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualization of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-28.
19. Ramani K, Judd RM, Holly TA, et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation 1998;98:2687-2694.
20. Germano G, Erel J, Lewin H, et al. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1997;30:1360-1367.
21. Eland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical assessment. Lancet 1986;1:307-310.
22. Fleiss J. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: Wiley & Sons; 1981.
23. 18F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2003;41:1341-1348.
24. Choi KM, Kim RJ, Gubernikoff G, et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-1107.
25. Sciagra R, Pellegri M, Pupi A, et al. Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2000;36:739-745.
26. Winbury MM. Redistribution of left ventncular blood flow produced by nitroglycerin: an example of integration of the macro- and microcirculation. Circ Res. 1971;28(suppl I):140-147.
27. Fujita M, Yamanishi K, Hirai T, et al. Significance of collateral circulation in reversible left ventricular asynergy by nitroglycerin in patients with relatively recent myocardial infarction. Am Heart J 1990;120:521-528.
28. Abrams J. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. Am J Cardiol 1992;70:30B-42B.
29. Tadamura E, Mamede M, Kubo S, et al. The effect of nitroglycerin on myocardial blood flow in various segments characterized by rest-redistribution thallium SPECT. J Nucl Med 2003;44:745-751.
30. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001;104:2838-2842.